DELLO SBARBA, PERSIO
 Distribuzione geografica
Continente #
NA - Nord America 6.943
EU - Europa 6.328
AS - Asia 1.106
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 14.416
Nazione #
US - Stati Uniti d'America 6.906
PL - Polonia 2.658
RU - Federazione Russa 1.540
SE - Svezia 555
IE - Irlanda 507
IT - Italia 415
CN - Cina 246
SG - Singapore 243
HK - Hong Kong 228
UA - Ucraina 163
DE - Germania 156
FI - Finlandia 113
IN - India 113
JO - Giordania 111
VN - Vietnam 91
GB - Regno Unito 89
CH - Svizzera 46
CA - Canada 37
CI - Costa d'Avorio 30
TR - Turchia 27
BE - Belgio 21
FR - Francia 18
ES - Italia 14
TW - Taiwan 14
AT - Austria 13
NL - Olanda 11
KR - Corea 8
TH - Thailandia 8
RO - Romania 6
SC - Seychelles 6
ID - Indonesia 4
IL - Israele 3
JP - Giappone 3
EU - Europa 2
KH - Cambogia 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
EE - Estonia 1
IR - Iran 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
SA - Arabia Saudita 1
Totale 14.416
Città #
Warsaw 2.658
Santa Clara 1.141
Fairfield 795
Chandler 614
Dublin 505
Woodbridge 428
Ashburn 410
Cambridge 346
Seattle 345
Jacksonville 308
Houston 287
Wilmington 275
Ann Arbor 204
Singapore 187
Florence 137
Princeton 133
Hong Kong 127
Boston 94
Lawrence 94
Beijing 93
Altamura 91
Boardman 88
Dong Ket 76
Mumbai 74
Buffalo 58
San Diego 57
Shanghai 53
Medford 47
Bern 42
Moscow 39
Falls Church 38
Kent 38
Pune 34
Abidjan 30
Munich 23
Norwalk 23
Brussels 21
Phoenix 20
Los Angeles 18
Ottawa 17
London 15
Toronto 15
Yubileyny 15
Andover 14
Redwood City 13
Siena 13
Daan 12
Izmir 11
Rome 11
Hillsboro 10
Milan 10
Helsinki 9
New York 9
Bangkok 8
Barcelona 8
Dearborn 8
Redmond 8
Vienna 8
Frankfurt Am Main 7
Tappahannock 7
Auburn Hills 6
Guangzhou 6
Prato 6
Turin 6
A Coruña 5
Fuzhou 5
Laurel 5
Renton 5
Costa Mesa 4
Dallas 4
Notre Dame 4
West Jordan 4
Bremen 3
Detroit 3
Düsseldorf 3
Kilburn 3
Kyoto 3
Lausanne 3
Lynchburg 3
Malang 3
Padova 3
Timisoara 3
Anghiari 2
Augusta 2
Bologna 2
Branford 2
Castel San Niccolò 2
Castelliri 2
Fremont 2
Garden Grove 2
Greenville 2
Hangzhou 2
Kaohsiung City 2
Karlskrona 2
Karlsruhe 2
Kochi 2
Montréal 2
Nanjing 2
Prescot 2
Rubano 2
Totale 10.405
Nome #
The Colony-Stimulating Factor-1 (CSF-1) Receptor Sustains ERK1/2 Activation and Proliferation in Breast Cancer Cell Lines. 302
One more stem cell niche: how the sensitivity of chronic myeloid leukemia cells to imatinib mesylate is modulated within a “hypoxic” environment 283
The metabolically-modulated stem cell niche: a dynamic scenario regulating cancer cell phenotype and resistance to therapy. 280
A comparative kinetic analysis of proliferation in vitro of con-A-treated splenocytes and syngeneic leukaemia cells. 272
The Leukemic Stem Cell Niche: Adaptation to “Hypoxia” versus Oncogene Addiction 270
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. 268
Targeting chronic myeloid leukemia stem cells with the hypoxia-inducible factor inhibitor acriflavine. 267
Metabolic aspects of cell cycle regulation in normal and cancer ceLLS. 263
Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets. 260
The complex metabolic network gearing the G1/S transition in leukemic stem cells: Hints to a rational use of antineoplastic agents. 258
Hypoxia selects bortezomib-resistant stem cells of chronic myeloid leukemia. 250
Chronic myeloid leukemia and hepatoblastoma: Two cancer models to link metabolism to stem cells 248
Colony-Stimulating Factor-1 Receptor in the Polarization of Macrophages: A Target for Turning Bad to Good Ones? 247
The expansion of murine bone marrow cells preincubated in hypoxia as an in vitro indicator of their marrow-repopulating ability. 242
Nerve growth factor inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation, and cytochrome c release 236
NGF inhibits apoptosis in memory B lymphocytes via inactivation of p38 MAPK, prevention of Bcl-2 phosphorylation and cytochrome c release. 219
Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells 213
Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. 211
Cancer stemness and progression: Mitochondria on the stage 195
The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma. 192
Severe hypoxia selects hematopoietic progenitors with stem cell potential from primary Myelodysplastic syndrome bone marrow cell cultures. 190
Low-dose methotrexate enhances cycling of highly anaplastic cancer cells. 178
Chronic myeloid leukemia progenitor cells require autophagy when leaving hypoxia-induced quiescence. 177
Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction 171
Beyond Kinase Activity: ERK5 Nucleo-Cytoplasmic Shuttling as a Novel Target for Anticancer Therapy 159
Fibronectin induces macrophage migration through a SFK-FAK/CSF-1R pathway 154
1,25-dihydroxyvitamin D3 and erk ½ map kinases in a human chronic myeloid leukemia cell line 147
Glucose availability in hypoxia regulates the selection of chronic myeloid leukemia progenitor subsets with different resistance to imatinib-mesylate 145
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 139
AML1/ETO sensitizes via TRAIL acute myeloid leukemia cells to the pro-apoptotic effects of hypoxia 138
In Vitro Comparison of the Effects of Imatinib and Ponatinib on Chronic Myeloid Leukemia Progenitor/Stem Cell Features 133
ACTIVATION OF THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 REGULATES THE DEVELOPMENT AND GROWTH OF HEPATOCELLULAR CARCINOMA 128
Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells 126
Severe hypoxia defines heterogeneity and selects highly immature progenitors within clonal erythroleukemia cells. 125
Cellule, tessuti e malattia - Principi di patologia generale 124
Prostaglandin E2 transactivates the colony-stimulating factor-1 receptor and synergizes with Colony-stimulating factor-1 in the induction of macrophage migration via the mitogen-activated protein kinase ERK1/2 124
Sensitivity to imatinib of KCL22 chronic myeloid leukemia cell survival/growth and stem cell potential under glucose shortage 123
Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO positive leukemia cells 122
APOPTOSIS - MOLECULAR REGULATION OF CELL DEATH AND HEMATOLOGIC MALIGNANCIES 119
ERK5/BMK1 is indispensable for optimal colony-stimulating factor 1 (CSF-1)-induced proliferation in macrophages in a Src-dependent fashion. 118
Apoptosis: molecular regulation of cell death and hematologic malignancies. 117
Interleukin-4 rapidly down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 117
Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. 114
The involvement of a Nanog, Klf4 and c-Myc transcriptional circuitry in the intertwining between neoplastic progression and reprogramming 114
Imatinib-mesylate enhances the maintenance of chronic myeloid leukemia stem cell potential in the absence of glucose. 114
HYPOXIA SUPPRESSES BCR/ABL AND SELECTS IMATINIB-INSENSITIVE PROGENITORS WITHIN CLONAL CML POPULATIONS. 112
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells. 110
Interleukin 2 down-modulates the macrophage colony-stimulating factor receptor in murine macrophages. 108
ACTIVATION OF ERK5, A MEMBER OF THE MAPK FAMILY, DIFFERENTIALLY REGULATES PROLIFERATION AND MIGRATION OF HEPATIC STELLATE CELLS 108
Alterations in CSF-1 receptor expression and protein tyrosine phosphorylation in autonomous mutants of a CSF-1 dependent macrophage cell line. 106
Environmental restrictions within tumor ecosystems select for a convergent hypoxia-resistant phenotype of cancer stem cells 106
Low Mr Phosphotyrosine Protein Phosphatase Associates and Dephosphorylates p125 Focal Adhesion Kinase, Interfering with Cell Motility and Spreading 105
Glutamine availability controls bcr/abl protein expression and functional phenotype of chronic myeloid leukemia cells endowed with stem/progenitor cell potential 105
Cytoskeletal rearrangement by the mitogen-activated protein kinase ERK5 interferes with the motile and invasive phenotype of hepatocellular carcinoma cells 105
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKAEMIA CELL LINE CAUSED BY ADMINISTRATION OF TWO HDAC INHIBITORS, VPA AND SAHA 104
ERK5 IS OVEREXPRESSED IN EXPERIMENTAL LIVER INJURY AND IN HEPATOCELLULAR CARCINOMA (HCC) AND IS MODULATED BY SOLUBLE FACTORS IN HCC CELLS 104
ERK5 differentially regulates PDGF-induced proliferation and migration of hepatic stellate cells. 103
Low M(r) phosphotyrosine protein phosphatase activity on fibroblast growth factor receptor is not associated with enzyme translocation. 102
Possible mechanisms and function of nuclear trafficking of the colony-stimulating factor-1 receptor. 102
Tumor angiogenesis: Thrombin and metalloproteinases in focus. 102
c-Rel AND p27Kip ARE DOWNSTREAM TARGETS OF ERK5 IN HEPATOCELLULAR CARCINOMA (HCC) IN VIVO AND IN VITRO 100
Tryptophan availability selectively limits NO-synthase induction in macrophages. 99
Focal adhesion kinase is redistributed to focal complexes and mediates cell spreading in macrophages in response to M-CSF. 99
Opposite effects of different doses of MCSF on ERK phosphorylation and cell proliferation in macrophages. 98
Constitutive activation of the MAPK pathway mediates v-fes-induced mitogenesis in murine macrophages. 94
CYTOSKELETAL REARRANGEMENT BY THE MITOGEN-ACTIVATED PROTEIN KINASE ERK5 INTERFERES WITH THE MOTILE AND INVASIVE PHENOTYPE OF HEPATOCELLULAR CARCINOMA CELLS 93
Inhibition of ERK5 elicits cellular senescence in melanoma via the cyclin-dependent kinase inhibitor p21 93
Salarin C inhibits maintenance of hypoxia-selected Chronic Myeloid Leukemia progenitor cells 92
Tissue Hypoxia and the Maintenance of Leukemia Stem Cells 91
The low-molecular-weight phosphotyrosine protein phosphatase, when overexpressed, reduces the mitogenic response to macrophage colony-stimulating factor and tyrosine phosphorylation of its receptor. 90
Functional specificity of cytoplasmic and transmembrane tyrosine kinases: identification of 130- and 75-kilodalton substrates of c-fps/fes tyrosine kinase in macrophages. 89
v-raf confers CSF-1-independent growth to a macrophage cell line and leads to immediate early gene expression without MAP-kinase activation. 89
Transmodulation of cell surface regulatory molecules via ectodomain shedding. 89
CITOKINE RECEPTOR SIGNAL TRANSDUCTION MECHANISMS IN IMMUNO-HEMATOPOIETIC CELLS 88
The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells 88
CXCR3 and αEβ7 integrin identify a subset of CD8+ mature thymocytes that share phenotypic and functional properties with CD8+ gut intraepithelial lymphocytes 87
Butyrates as single drug induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts. 86
CSF1 Determines CSF1R Cytoplasmic Nuclear Shuttling in Breast Cancer Cells 85
Independently arising macrophage mutants dissociate growth factor-regulated survival and proliferation. 85
Acriflavine targets oncogenic STAT5 signaling in myeloid leukemia cells 84
CHARACTERIZATION OF SIGNALS LINKING THE MACROPHAGE COLONY-STIMULATING FACTOR RECEPTOR TO THE FOCAL ADHESION KINASE 83
Targeting chronic myeloid leukemia stem cells with ERK5 pathway inhibitors 82
Slow-cycling/quiescence balance of hematopoietic stem cells is related to physiological gradient of oxygen. 82
GLEEVEC-RESISTANT CML STEM AND PROGENITOR CELLS ARE SENSITIVE TO HIF-INHIBITING DRUGS 82
The Culture-Repopulating Ability Assays and Incubation in Low Oxygen: A Simple Way to Test Drugs on Leukaemia Stem or Progenitor Cells 81
GLUCOSE AVAILABILITY IN HYPOXIA REGULATES THE SELECTION OF CML PROGENITOR SUBSETS WITH DIFFERENT RESISTANCE TO IMATINIB-MESYLATE 80
Hemopoietic progenitor cells are sensitive to the cytostatic effect of pyruvate. 80
SPECIFIC DEGRADATION OF THE AML1-ETO/COREPRESSOR COMPLEX BY A NOVEL ORAL HYDROXAMIC ACID DERIVATIVE 78
MAPKS ARE INVOLVED IN THE SURVIVAL AND DIFFERENTIATION OF A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE AND ARE MODULATED BY THE HDAC INHIBITOR D1 78
INCUBATION OF MURINE ERYTHROLEUKEMIA CELLS IN SEVERE HYPOXIA INDUCES MASSIVE APOPTOSIS PARALLELED BY AKT AND ERK5 CLEAVAGE 78
Lactate maintainsBCR/Abl expression and signalinginChronic Myeloid Leukemia cells under nutrient restriction 78
Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro. 77
ENERGY RESTRICTION REGULATES BCR/ABL EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELLS VIA TRANSCRIPTIONAL/POST-TRANSCRIPTIONAL CONTROL 77
HDAC INHIBITORS IN COMBINATION WITH HYPOMETHYLATING AGENTS INDUCE SPECIFIC CHROMATIN MODIFICATION AND TRANSCRIPTIONAL ACTIVATION IN CBF/AML CELLS 76
HYPOXIA SELECTS DRUG-INSENSITIVE PROGENITORS WITHIN CLONAL LEUKAEMIA CELL POPULATIONS 76
ERK5 inhibition elicits cellular senescence in human melanoma cells 75
Hypoxia maintains and IL3 reduces the pre-CFC potential of dividing CD34+ murine bone marrow cells. 74
BORTEZOMIB SPECIFICALLY TARGETS A SUBSET OF HYPOXIA-SELECTED CML STEM CELLS 73
EPIGENETIC MODIFICATIONS IN A T(8;21) ACUTE MYELOID LEUKEMIA CELL LINE CAUSED BY ADMINISTRATION OF THE HDAC INHIBITOR D1 71
TRAIL IS INVOLVED IN HYPOXIA-INDUCED APOPTOSIS OF ACUTE MYELOID LEUKEMIA T(8;21)-POSITIVE CELLS 70
Totale 13.344
Categoria #
all - tutte 36.144
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.771 0 0 0 0 265 273 231 337 224 159 240 42
2020/20211.761 137 165 84 237 77 210 84 148 145 238 81 155
2021/2022914 34 76 48 60 48 49 36 60 55 50 154 244
2022/20232.414 215 354 121 193 186 429 326 143 291 16 70 70
2023/2024864 45 82 123 45 66 124 52 181 21 22 68 35
2024/20253.469 199 596 346 888 1.440 0 0 0 0 0 0 0
Totale 14.570